FindTrial
Sign In

A study to compare efficacy of carbetocin versus oxytocin for prevention of post partum hemorrhage.

A randomized controlled, open labelled clinical trial comparing the efficacy of carbetocin versus oxytocin in prevention of post partum hemorrhage. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081722
Enrollment
170
Registered
2025-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: INTERVENTION DONE IN CASE OF CARBETOCIN VERSUS OXYTOCIN FOR PREVENTION OF POST PARTUM HEMORRHAGE: AIM •To assess the efficacy of carbetocin and oxytocin in preventing post-partum haemo

Sponsors

DR. V. BHUVANESHWARAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women aged 18 yrs to 50 years. 2.Multiple pregnancy. 3.Scheduled for Elective cesarean section under spinal anaesthesia. 4.Prolonged third stage labour. 5.Fetal macrosomia. 6.History of post partum hemorrhage. 7.Grand multiparity. 8.Placenta previa. 9.Placental abruption. 10.Pregnancy induced hypertension. 11.ASA I and II.

Exclusion criteria

Exclusion criteria: 1.Patient refusal. 2.History of thromboembolic disorder. 3.Patients suffering from other chronic illness like COPD or any active LRTI. 4.Preexisting neuropathy. 5.Eclampsia and HELLP syndrome. 6.Contraindication to Spinal anesthesia. 7.Any known allergy to local anaesthetia or general anaesthesia.

Design outcomes

Primary

MeasureTime frame
Primary outcome is to compare the efficacy of carbetocin and oxytocin in preventing intraoperative blood lossTimepoint: 1.(T0) at carbetocin /oxytocin injection. 2.(T1) end of operation procedure. 3. (T3) 2 hr post operative period. 4. (T4) 12 hr post operative period.—

Secondary

MeasureTime frame
haemodynamic variableTimepoint: after administering two drugs take taken in T1 min T3min T5min T10min T15min T45min T60min T75min T90min—

Countries

India

Contacts

Public ContactDr. Deepannita sutradhar
dipanitasutradhar@gmail.com7002209146

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026